Edetate Disodium USP (VERSENE™ NA)

Edetate Disodium USP (VERSENE™ NA)
Product Description

VERSENE™NA Chelating Agent is an effective stabilizer and preservative for pharmaceutical preparations, including medicated creams and ointments, ocular care, syrups and elixirs. This Edetate Disodium USP-grade product controls metal ions present in pharmaceutical formulations or processes. Product Benefits:- Well suited for applications calling for neutral pH or mildly acidic conditions common to most food and pharmaceutical products
- Functionally able to chemically bind and render inactive trace metals having an adverse impact on the color, flavor, clarity, shelf life, and other characteristics 
- Used in cosmetic and personal care applications such as creams, oils, ointments, perfumes and hair preparations
- VERSENE™NA is a a preservative for its ability to preserve color, flavor, and quality of food products
Visit our product page to know more: https://www.dow.com/en-us/product-technology/pt-amines/pg-amines-chelants.html.html

Dow

  • US
  • 2018
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    6381-92-6
  • Supplied from
    United States

Dow

  • US
  • 2018
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Dow (3)

  • CARBOWAX™ SENTRY™ Polyethylene Glycol (PEG)

    Product CARBOWAX™ SENTRY™ Polyethylene Glycol (PEG)

    CARBOWAX™ SENTRY™ PEGs common applications include: carrier/plasticizer in gel capsules, base for face/neck lotions, providing formulation stability in toothpaste, binder for tablets, shampoo wetting agent, and more. CARBOWAX™ SENTRY™ PEGs are available in average molecular weights ranging from 300 ...
  • High Purity Solvents for API Manufacturing

    Product High Purity Solvents for API Manufacturing

    Detailed impurity profiles are available for industrial grade solvents. In addition, multiple high purity solvents are available:
    - Phenoxyethanol /DOWANOL™ EPh NF: CAS: 122-99-6
    - Isopropyl Alcohol /Isopropanol AnhydrousUSP/EP: CAS: 67-63-0
    - Propionic acid FC...
  • Processing aids – surfactants: TRITON X-100 & TERGITOL 15-S-9

    Product Processing aids – surfactants: TRITON X-100 & TERGITOL 15-S-9

    Large Molecule (Biologic) API Production:

    Dow’s TRITON™ and TERGITOL™ surfactants are used to inactivate virus envelopes, lyse cells, and buffer RNA extraction solutions.  As the only producer of TRITON™ X-100 (CAS No: 9036-19-5), which has been trusted by the industry for decades...

Dow resources (3)

  • News Dow announces new alkoxylation capacity in U.S. and Europe to meet continued robust demand growth

    New capacity to support global growth in key end-markets delivering 10% to 15% annual growth rates. This builds on previously announced capacity expansions, increasing the company's global alkoxylation capacity by 70% vs. 2020 baseline, collectively. Higher return and faster-payback projects expected to come online in 2024 and 2025. 
  • Brochure CARBOWAX™ and CARBOWAX™ SENTRY™ Polyethylene Glycols (PEGs)

    CARBOWAX™ and CARBOWAX™ SENTRY™ Polyethylene Glycols (PEGs) are highly versatile excipients and active pharmaceutical ingredients (APIs) produced to meet the exacting requirements of the pharmaceutical industry
  • Video Reimagining How You Work with Your Excipient Supplier: Product Quality Beyond Compendial Requirements

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. One of the top priorities of pharmaceutical companies in bringing new products to market is to prove a drug substance is safe and effective against a certain illness. As you would expect, especially in the beginning stages of development, companies primarily focus on the API itself and not necessarily the excipients that will go into the final drug product. Instead, compendial requirements and guidelines such as those from ICH exist to ensure excipient quality and safety. Not only this is important from a regulatory perspective, but excipient quality can also impact product performance, even if those excipients meet all compendial requirements. In this session, you will learn about: Recent regulatory developments relating to residual impurities in pharmaceutical excipients Challenges in analytical methods to meet increasingly stringent targets How you can work with your excipient supplier to ensure high product quality